Outcomes of IVF programs with intrauterine administration of autologous mononuclear cells in women with repeated implantation failure

Cover Page

Cite item

Abstract

Frequency of the repeated implantation failure (RIF) in assisted reproductive technology programs remains to be high, reaching 50-75%. Intrauterine administration of autologous mononuclear cells before embryo transfer is a technique for the RIF immunocorrection being used in assisted reproductive technology programs. Direct effect of mononuclear cells upon implantation was first studied in 2006 and showed that intrauterine administration of autologous mononuclear cells prior to embryo transfer proved to significantly increase implantation frequency, as well as incidence of clinical pregnancy, and frequency of delivery in the patients with a history of RIF. The aim of this study was to evaluate the effect of intrauterine administration of autologous peripheral blood mononuclear cells prior to embryo transfer upon the results of assisted reproductive technology programs in women with a history of RIF, and to evaluate cytokine profile of the supernates from the injected cultures of peripheral blood mononuclear cells.
The study included 129 women with RIF included into the assisted reproductive technology programs. The patients were divided into three groups with intrauterine administration before embryo transfer in a stimulated cycle and in a cryocycle: group 1, treated with mononuclear cells activated by human chorionic gonadotropin; group 2, with mononuclear cells without activation by human chorionic gonadotropin; group 3 who received saline solution (placebo). Clinical and anamnestic data of the women from these groups did not differ. The age of women in all three groups was also similar. The number of RIFs in their anamnesis was comparable for the 3 groups. Analysis of the embryological parameters also showed that there were no significant differences in the number of transferred embryos, including those of good quality.
The levels of IL-2 (p = 0.006), IL-4 (p = 0.012), IL-5 (p = 0.012), IL-12p70 (p = 0.011), IFNγ (p = 0.012), GM-CSF (p = 0.026), and TNFα (p = 0.021) were found to be higher in the supernatants of human chorionic gonadotropin-activated mononuclear cells of women with advanced cryocycle implantation, than in supernatants of inactivated chorionic gonadotropin mononuclear cells. Frequencies of implantation and clinical pregnancy were significantly higher in the groups with intrauterine administration of autologous mononuclear cells, both in stimulated cycle and the cryocycle compared to the placebo groups.
The cytokine profile of the mononuclear cell culture supernates upon intrauterine administration affects the efficiency of assisted reproductive technology programs in the women with RIF. Hence, the data obtained may allow us to develop a personalized approach to usage of various immunotherapies in assisted reproductive technology programs for the patients with a history of repeated implantation failure.

About the authors

V. V. Vtorushina

V. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology

Author for correspondence.
Email: vtorushina@inbox.ru

PhD (Medicine), Doctor for Clinical Laboratory Diagnostics

117997, Moscow, Acad. Oparin str., 4

Russian Federation

L. V. Krechetova

V. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology

Email: k_l_v_@mail.ru

MD, PhD (Medicine), Head, Laboratory of Clinical Immunology

117997, Moscow, Acad. Oparin str., 4

S. G. Perminova

V. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology

Email: perisvet@list.ru

MD, PhD (Medicine), Leading Research Associate

117997, Moscow, Acad. Oparin str., 4

References

  1. Амян Т.С., Кречетова Л.В., Перминова С.Г., Вторушина В.В. Эффективность внутриматочного введения аутологичных мононуклеарных клеток периферической крови перед переносом эмбриона у пациенток с повторными неудачами имплантации в программах вспомогательных репродуктивных технологий // Гинекология, 2018. Т. 2, № 2. С. 28-33.
  2. Huang P. Effects of intrauterine perfusion of human chorionic gonadotropin in women with different implantation failure numbers. Am. J. Reprod. Immunol., 2018, Vol. 79, no. 2. doi: 10.1111/aji.12809.
  3. Imakawa K., Bai R., Fujiwara H., Kusama K. Conceptus implantation and placentation: molecules related to epithelial-mesenchymal transition, lymphocyte homing, endogenous retroviruses, and exosomes. Reprod. Med. Biol., 2016, Vol. 15, no. 1, pp. 1-11.
  4. Lea R.G., Sandra O. Immunoendocrine aspects of endometrial function and implantation. Reproduction, 2007, Vol. 134, pp. 389-404.
  5. Makrigiannakis A., BenKhalifa M., Vrekoussis T., Mahjub S., Kalantaridou S.N. Gurgan: repeated implantation failure: a new potential treatment option. Eur. J. Clin. Invest., 2011, Vol. 45, pp. 380-384.
  6. Nakayama T., Fujiwara H., Maeda M. Human peripheral blood mononuclear cells (PBMC) in early pregnancy promote embryo invasion in vitro: hCG enhances the effects of PBMC. Hum. Reprod., 2002, Vol. 17, pp. 207-212.
  7. Okitsu O., Kiyokawa M., Oda T., Miyake K., Sato Y., Fujiwara H. Intrauterine administration of autologous peripheral blood mononuclear cells increases clinical pregnancy rates in frozen/thawed embryo transfer cycles of patients with repeated implantation failure. J. Reprod. Immunol., 2011, Vol. 92, pp. 82-87.
  8. Saito S., Nakashima A., Shima T., Ito M., Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol., 2010, Vol. 63, pp. 601-610.
  9. Santibañez A., García J., Pashkova O., Colín O., Castellanos G., Sánchez A.P., De la Jara J.F. Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilisation cycles: a prospective study. Reprod. Biol. Endocrinol., 2014, Vol. 12, 9. doi: 10.1186/1477-7827-12-9.
  10. Takabatake K., Fujiwara H., Goto Y., Nakayama T., Higuchi T., Fujita J., Maeda M., Mori T. Splenocytes in early pregnancy promote embryo implantation by regulating endometrial differentiation in mice. Hum. Reprod., 1997, Vol. 12, pp. 2102-2107.
  11. Yoshinaga K. Review of factors essential for blastocyst implantation for their modulating effects on the maternal immune system. Semin. Cell. Dev. Biol., 2008, Vol. 19, pp. 161-169.
  12. Yoshioka S., Fujiwara H., Nakayama T., Kosaka K., Mori T., Fujii S. Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF-embryo transfer. Hum. Reprod., 2006, Vol. 21, pp. 3290-3294.
  13. Yu N., Yang J., Guo Y., Fang J., Yin T., Luo J., Li X., Li W., Zhao Q., Zou Y., Xu W. Intrauterine administration of peripheral blood mononuclear cells (PBMCs) improves endometrial receptivity with embryonic implantation dysfunction. Am. J. Reprod. Immunol., 2014, Vol. 71, pp. 24-33.
  14. Zeyneloglu H.B., Onalan G. Remedies for recurrent implantation failure. Semin. Reprod. Med., 2014, Vol. 32, pp. 297-305.

Supplementary files

There are no supplementary files to display.


Copyright (c) 2021 Vtorushina V.V., Krechetova L.V., Perminova S.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Свидетельство о регистрации СМИ ПИ № 77 - 11525 от 04.01.2002 выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies